This is an online survey study that was conducted in Saudi Arabia between December 2024 and January 2025 to examine community awareness and attitudes regarding the use of GLP-1 agonists as a treatment for obesity in Saudi Arabia. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.